Rare diseases
Investigational molecules
Locations
Back to Hungary560 clinical trials in Debrecen, Hungary across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study on Long-Term Safety and Efficacy of Deucravacitinib for Patients with Moderate-to-Severe Plaque Psoriasis
HungaryStudy of Evolocumab to Prevent Heart Disease Events in High-Risk Patients Without Previous Heart Attack or Stroke
HungaryStudy on the Effects of Human Normal Immunoglobulin in Adults with Dermatomyositis
HungaryStudy of resmetirom (MGL-3196) in patients with Non-Alcoholic Steatohepatitis (NASH) to prevent liver damage and disease progression
HungaryStudy on Long-Term Safety and Effectiveness of Abrocitinib for Patients Aged 12 and Older with Moderate to Severe Atopic Dermatitis
HungaryHungaryStudy of Olezarsen (ISIS 678354) in Patients with Severe Hypertriglyceridemia: Testing Effects on Triglyceride Levels
HungaryStudy of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease
HungaryStudy on the Effectiveness and Safety of Guselkumab for Patients with Moderate to Severe Ulcerative Colitis
HungaryStudy of anifrolumab effectiveness compared to placebo in adults aged 18-70 with systemic sclerosis
HungarySafety Study of Efgartigimod in Adults with Primary Sjögren's Syndrome
HungaryStudy on Asundexian for Preventing Ischemic Stroke in Adults After a Stroke or High-Risk Mini-Stroke
HungaryThe busiest research cities in the country
What the registry says about research in the country
Comprehensive studies evaluating novel treatments for plaque psoriasis and chronic urticaria. Multiple trials are investigating innovative therapies for both moderate to severe cases, including genital manifestations.
Focus on long-term safety and efficacy of new therapeutic agents for chronic skin conditions.
Leading research into heart failure prevention and cardiovascular disease management. Trials examining innovative treatments and preventive approaches for high-risk patients.
Emphasis on reducing major cardiovascular events and improving patient outcomes.
Groundbreaking research addressing obesity and type 2 diabetes. Studies evaluating combination therapies and novel approaches for weight management in diverse patient populations.
Investigation of treatments combining weight reduction with diabetes management.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
